138 related articles for article (PubMed ID: 19624891)
1. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer].
Zheng XY; Qi YM; Gao YF; Wang XY; Qi MX; Shi XF; An XL
Ai Zheng; 2009 Jul; 28(7):679-84. PubMed ID: 19624891
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of a disintegrin and metalloprotease 8 (ADAM8) and epidermal growth factor receptor (EGFR) in non-small cell lung cancer].
Wu GC; Hu HC; Shi MH
Ai Zheng; 2008 Aug; 27(8):874-8. PubMed ID: 18710625
[TBL] [Abstract][Full Text] [Related]
3. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].
Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH
Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657
[TBL] [Abstract][Full Text] [Related]
4. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.
Chen ZL; Zhao SH; Wang Z; Qiu B; Li BZ; Zhou F; Tan XG; He J
Chin J Cancer; 2011 Jan; 30(1):62-8. PubMed ID: 21192845
[TBL] [Abstract][Full Text] [Related]
5. [Significance of caveolin-1 expression in primary lung cancer].
Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
[TBL] [Abstract][Full Text] [Related]
6. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
[TBL] [Abstract][Full Text] [Related]
7. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of Elf-1 and vascular endothelial growth factor in non-small cell lung cancer].
Yang DX; Han YC; Liu LY; Yu N; Wang X; Shi Y
Ai Zheng; 2009 Jul; 28(7):762-7. PubMed ID: 19624906
[TBL] [Abstract][Full Text] [Related]
10. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of the expression of III β-tubulin and MDR1 protein with biological features of non-small cell lung cancer].
Hu LH; Wu Y; Lu GH; Chen QY; Wang YH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):762-6. PubMed ID: 21163067
[TBL] [Abstract][Full Text] [Related]
12. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
[TBL] [Abstract][Full Text] [Related]
13. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients.
Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX
Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211
[TBL] [Abstract][Full Text] [Related]
14. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
[TBL] [Abstract][Full Text] [Related]
15. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
Wang X; Du Z; Li L; Shi M; Yu Y
Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
17. [Expression of granulocyte colony stimulating factor in patients with non-small cell lung cancer and its clinicopathological significance].
Wei LX; Chang WL; Guo AT; Tai YH; Sun L; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):721-5. PubMed ID: 22336152
[TBL] [Abstract][Full Text] [Related]
18. [Expression of EYA2 in non-small cell lang cancer].
Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
[TBL] [Abstract][Full Text] [Related]
19. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
Huang G; Song H; Wang R; Han X; Chen L
J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
